Elanco Beats Investor Suit Over Dog Drug's Reg Challenges
By Katryna Perera · March 26, 2026, 8:58 PM EDT
A Maryland federal judge Thursday dismissed a proposed securities class action against Elanco Animal Health Inc. that claimed the animal pharmaceuticals company misled investors about the safety of a canine dermatitis...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login